DENISE GILANYI: Open Payments
NPI 1346941606 · KENOSHA, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$838 in 55 payments from 7 companies in 2025. Trend: 2023 $132 · 2024 $854 · 2025 $838
Food & beverage: $838
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $200 |
| ABBVIE INC. | 11 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $183 |
| Lundbeck LLC | 8 | $145 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Braeburn Inc. | 1 | $16 |
Products named: Auvelity, VRAYLAR, CAPLYTA, REXULTI, TRINTELLIX, INGREZZA, BRIXADI.
Industry payments across WI — which companies pay providers there.
